Mtg16/Eto2 contributes to murine T-cell development

Molecular and Cellular Biology

Volumn 31, Issue 13, 2011, Pages 2544-2551

  Hunt, Aubrey ^a   Fischer, Melissa ^a   Engel, Michael E ^a,b,c   Hiebert, Scott W ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FATE; CELL MATURATION; GENE; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYELOID TRANSLOCATION GENE 16; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYMOCYTE; TRANSCRIPTION INITIATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MARROW TRANSPLANTATION; CELL LINEAGE; GENETIC COMPLEMENTATION TEST; LYMPHOPOIESIS; MICE; MICE, MUTANT STRAINS; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, NOTCH; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

MURINAE; MUS;

EID: 79959457475     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01458-10     Document Type: Article

References (48)

1. Amann, J. M., et al. 2001. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol. Cell. Biol. 21:6470-6483.
2. Bain, G., et al. 1997. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17:4782-4791.
3. Bain, G., et al. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885-892.
4. Bain, G., M. W. Quong, R. S. Soloff, S. M. Hedrick, and C. Murre. 1999. Thymocyte maturation is regulated by the activity of the helix-loop-helix protein, E47. J. Exp. Med. 190:1605-1616.
5. Barndt, R., M. F. Dai, and Y. Zhuang. 1999. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis. J. Immunol. 163:3331-3343.
6. Benezra, R., R. L. Davis, D. Lockshon, D. L. Turner, and H. Weintraub. 1990. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
7. Bhalla, S., et al. 2008. Differential roles for the E2A activation domains in B lymphocytes and macrophages. J. Immunol. 180:1694-1703.
8. Blobel, G. A. 2000. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 95:745-755.
9. Cai, Y., et al. 2009. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors. Biochem. Biophys. Res. Commun. 390:295-301.
10. Chyla, B. J., et al. 2008. Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation. Mol. Cell. Biol. 28:6234-6247.
11. Cochrane, S. W., Y. Zhao, R. S. Welner, and X. H. Sun. 2009. Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions. Blood 113:1016-1026.
12. Corpora, T., et al. 2010. Structure of the AML1-ETO NHR3-PKA(RIIalpha) complex and its contribution to AML1-ETO activity. J. Mol. Biol. 402:560-577.
13. Dias, S., R. Mansson, S. Gurbuxani, M. Sigvardsson, and B. L. Kee. 2008. E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity 29:217-227.
14. Engel, M. E., H. N. Nguyen, J. Mariotti, A. Hunt, and S. W. Hiebert. Myeloid translocation gene 16 (MTG16) interacts with Notch transcription complex components to integrate Notch signaling in hematopoietic cell fate specification. Mol. Cell. Biol. 30:1852-1863.
15. Erickson, P., et al. 1992. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80:1825-1831.
16. Fukuyama, T., et al. 2001. MTG8 proto-oncoprotein interacts with the regulatory subunit of type II cyclic AMP-dependent protein kinase in lymphocytes. Oncogene 20:6225-6232.
17. Gamou, T., et al. 1998. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood 91:4028-4037.
18. Gelmetti, V., et al. 1998. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol. Cell. Biol. 18:7185-7191.
19. Goardon, N., et al. 2006. ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J. 25:357-366.
20. Guo, C., Q. Hu, C. Yan, and J. Zhang. 2009. Multivalent binding of the ETO corepressor to E proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery. Mol. Cell. Biol. 29:2644-2657.
21. Ikawa, T., H. Kawamoto, A. W. Goldrath, and C. Murre. 2006. E proteins and Notch signaling cooperate to promote T cell lineage specification and commitment. J. Exp. Med. 203:1329-1342.
22. Ikawa, T., H. Kawamoto, L. Y. Wright, and C. Murre. 2004. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 20:349-360.
23. Jepsen, K., et al. 2000. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102:753-763.
24. Kee, B. L., G. Bain, and C. Murre. 2002. IL-7Ralpha and E47: independent pathways required for development of multipotent lymphoid progenitors. EMBO J. 21:103-113.
25. Kitabayashi, I., et al. 1998. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol. Cell. Biol. 18:846-858.
26. Kovall, R. A. 2008. More complicated than it looks: assembly of Notch pathway transcription complexes. Oncogene 27:5099-5109.
27. Laiosa, C. V., M. Stadtfeld, and T. Graf. 2006. Determinants of lymphoidmyeloid lineage diversification. Annu. Rev. Immunol. 24:705-738.
28. Liu, Y., et al. 2006. The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. Cancer Cell 9:249-260.
29. Luc, S., N. Buza-Vidas, and S. E. Jacobsen. 2008. Delineating the cellular pathways of hematopoietic lineage commitment. Semin. Immunol. 20:213-220.
30. Lutterbach, B., D. Sun, J. Schuetz, and S. W. Hiebert. 1998. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol. Cell. Biol. 18:3604-3611.
31. Lutterbach, B., et al. 1998. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol. Cell. Biol. 18:7176-7184.
32. Mansson, R., et al. 2007. Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors. Immunity 26:407-419.
33. Miyoshi, H., et al. 1993. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 12: 2715-2721.
34. Moore, A. C., et al. 2008. Myeloid translocation gene family members associate with T-cell factors (TCFs) and influence TCF-dependent transcription. Mol. Cell. Biol. 28:977-987.
35. Plevin, M. J., J. Zhang, C. Guo, R. G. Roeder, and M. Ikura. 2006. The acute myeloid leukemia fusion protein AML1-ETO targets E proteins via a paired amphipathic helix-like TBP-associated factor homology domain. Proc. Natl. Acad. Sci. U. S. A. 103:10242-10247.
36. Radtke, F., et al. 1999. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10:547-558.
37. Rice, K. L., I. Hormaeche, and J. D. Licht. 2007. Epigenetic regulation of normal and malignant hematopoiesis. Oncogene 26:6697-6714.
38. Salat, D., R. Liefke, J. Wiedenmann, T. Borggrefe, and F. Oswald. 2008. ETO, but not leukemogenic fusion protein AML1/ETO, augments RBPJkappa/ SHARP-mediated repression of notch target genes. Mol. Cell. Biol. 28:3502-3512.
39. Schmitt, T. M., and J. C. Zuniga-Pflucker. 2002. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17:749-756.
40. Schotte, R., et al. 2010. Synergy between IL-15 and Id2 promotes the expansion of human NK progenitor cells, which can be counteracted by the E protein HEB required to drive T cell development. J. Immunol. 184:6670-6679.
41. Schuh, A. H., et al. 2005. ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. Mol. Cell. Biol. 25:10235-10250.
42. Schwartz, R., I. Engel, M. Fallahi-Sichani, H. T. Petrie, and C. Murre. 2006. Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development. Proc. Natl. Acad. Sci. U. S. A. 103:9976-9981.
43. Semerad, C. L., E. M. Mercer, M. A. Inlay, I. L. Weissman, and C. Murre. 2009. E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors. Proc. Natl. Acad. Sci. U. S. A. 106:1930-1935.
44. Sun, X. H., N. G. Copeland, N. A. Jenkins, and D. Baltimore. 1991. Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helixloop-helix proteins. Mol. Cell. Biol. 11:5603-5611.
45. Wei, Y., et al. 2007. A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription. Nat. Struct. Mol. Biol. 14:653-661.
46. Yan, M., et al. 2006. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat. Med. 12:945-949.
47. Yang, Q., B. Esplin, and L. Borghesi. 2011. E47 regulates hematopoietic stem cell proliferation and energetics but not myeloid lineage restriction. Blood 117:3529-3538.
48. Zhang, J., M. Kalkum, S. Yamamura, B. T. Chait, and R. G. Roeder. 2004. E protein silencing by the leukemogenic AML1-ETO fusion protein. Science 305:1286-1289.